首页> 外文期刊>Bulletin of the World Health Organization >The challenges of introducing a malaria vaccine
【24h】

The challenges of introducing a malaria vaccine

机译:引进疟疾疫苗的挑战

获取原文
       

摘要

Malcolm Molyneux is tracking progress in the fight against malaria and the safety and efficacy of the new malaria vaccine, RTS,S. Molyneux trained at Cambridge University and Bart's Hospital in London, United Kingdom of Great Britain and Northern Ireland and, after several appointments as a junior doctor, he went to work in Malawi in 1974 as a government specialist in medicine based at the Queen Elizabeth Central Hospital in Blantyre, Malawi. In 1984, he became senior lecturer – later professor – at the Liverpool School of Tropical Medicine, and returned to Malawi in 1995, where he worked principally in malaria, with a special interest in the treatment of severe disease in children. Molyneux directed the Blantyre base of the Malawi Liverpool Wellcome Trust Clinical Research Programme from 1995 until 2007 and continues to participate in its malaria research programme. He is a member of several data committees for international trials, and has chaired the Independent Data Monitoring Committee for the vaccine RTS,S for the past decade. Since 2015 he has been emeritus professor at the Liverpool School.
机译:马尔科姆·莫里纽克斯(Malcolm Molyneux)正在追踪抗击疟疾的进展以及新型疟疾疫苗RTS,S的安全性和有效性。 Molyneux在剑桥大学和大不列颠及北爱尔兰联合王国伦敦的巴特医院接受培训,在多次被任命为初级医生之后,他于1974年在马拉维工作,担任伊丽莎白女王中央医院的政府医学专家。在马拉维的布兰太尔。 1984年,他成为利物浦热带医学院的高级讲师,后来成为教授。1995年,他回到马拉维,主要从事疟疾工作,对治疗儿童严重疾病特别感兴趣。从1995年到2007年,Molyneux领导着马拉维利物浦惠康信托基金会临床研究计划的Blantyre基地,并继续参与其疟疾研究计划。他是多个国际试验数据委员会的成员,并且在过去十年中担任RTS,S疫苗独立数据监测委员会的主席。自2015年以来,他一直是利物浦学校的名誉教授。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号